This is the abstract from a new study from Germany that looks at the PI3K/AKT signaling in synovial sarcoma and the use of LY294002 in vitro to inhibit it:
http://www.ncbi.nlm.nih.gov/pubmed/21128248
Of course this is just an in vitro study and many of such studies never translate into clinical trials but it gives an insight into one piece of a huge puzzle that is synovial sarcoma…